AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ELEVRA LITHIUM LTD

4.990

-0.210-4.04%

Volume:2.32M

Turnover:11.65M

Market Cap:968.14M

PE:12.92

High:5.200

Open:5.200

Low:4.920

Close:5.200

52wk High:14.060

52wk Low:3.670

Shares:194.02M

Float Shares:166.89M

Volume Ratio:1.15

T/O Rate:1.39%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.386

EPS(LYR):0.386

ROE:8.55%

ROA:4.36%

PB:0.93

PE(LYR):12.92

Loading ...

Overview Company News Filings

Elevra Lithium Posts Lower Fiscal Q4 Spodumene Concentrate Production From Canada Operations; Shares Down 3%

MT Newswires Live

Press Release: Elevra Lithium Quarterly Activities Report

Lynas Rare Earths Stock And 2 Australian Miners With Strong Growth Outlook

Simply Wall St.

3 Australian Mining Stocks With Strong Balance Sheets And High Growth Potential

Simply Wall St.

Elevance Health (ELV) Lifted Full Year Guidance, Is The 11% Undervaluation Still There?

Simply Wall St.

Elevra Lithium Schedules June Quarterly Results Webcast

Elevance Health (ELV) Stock Still Looks Discounted Despite A 38% Gain

Simply Wall St.

Elevance Health (ELV) Raises 2026 Targets And Exits Weak Medicaid Markets

Simply Wall St.

Lynas Rare Earths Stock And 2 ASX Miners With Big Growth Plans

Simply Wall St.

Elevance Health's Strong Q2 Prompts Higher 2026-27 Estimates, Truist Says

MT Newswires Live

Elevance Health Stock Weakness Despite Q2 Beat Reflects Medicaid Utilization Pressure, RBC Capital Markets Says

MT Newswires Live

Is Elevra Lithium (ASX:ELV) Undervalued Following Its Fully Funded North American Lithium Expansion?

Simply Wall St.

Elevra Lithium Ltd-elv Egm - Chair Address and Egm Slides

THOMSON REUTERS

Top Midday Decliners

MT Newswires Live

GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS of At Least $27, vs. FactSet Est of $26.87

MT Newswires Live

US Stock Market Today: S&P 500 Futures Climb On Cooler Global Inflation And Yields

Simply Wall St.

Elevance Health (ELV) Stock Looks Reasonable On Earnings But Stretched After 25% Gain

Simply Wall St.

Australia's Elevra Lithium Falls to Near Three-month Low on Lower Production, Sales

ASX Biggest Losers

MT Newswires Live

Elevra Lithium Says North American Lithium Produces 54,479 Dmt Spodumene Concentrate in June Qtr

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/ELV.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ELV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ELV.AU\",,,,,undefined,":{"symbol":"ELV.AU","market":"AU","secType":"STK","nameCN":"ELEVRA LITHIUM LTD","latestPrice":4.99,"timestamp":1791436320000,"preClose":5.2,"halted":0,"volume":2321412,"delay":0,"changeRate":-0.04038461538461537,"nameEN":"ELEVRA LITHIUM LTD","floatShares":166890429,"shares":194016000,"eps":0.3861259369020731,"marketStatus":"Closed","change":-0.21,"latestTime":"10-08 16:12:00 AEDT","open":5.2,"high":5.2,"low":4.92,"amount":11650603,"amplitude":0.053846,"askPrice":5,"askSize":600,"bidPrice":4.95,"bidSize":1576,"shortable":3,"etf":0,"ttmEps":0.3861259369020731,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":5.2,"openAndCloseTimeList":[[1791414000000,1791435600000]],"volumeRatio":1.147341,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ELV.AU","preClose":5.2,"auctionPrice":4.99,"auctionVolume":327307,"auctionTime":1791436203502,"referencePrice":4.99,"referenceTime":1791438120453,"auction":3,"marketStatus":"盘后竞价","timestamp":1791436203502}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ELV.AU\",,,,,undefined,":{"symbol":"ELV.AU","floatShares":166890429,"roa":"4.36%","roe":"8.55%","lyrEps":0.386126,"volumeRatio":1.147341,"shares":194016000,"dividePrice":0,"high":5.2,"amplitude":0.053846,"preClose":5.2,"low":4.92,"week52Low":3.67,"pbRate":"0.93","psRate":"3.33","week52High":14.06,"institutionHeld":0,"latestPrice":4.99,"committee":0.448529,"eps":0.3861259369020731,"divideRate":0,"volume":2321412,"delay":0,"ttmEps":0.3861259369020731,"open":5.2,"prevYearClose":8.04,"prevWeekClose":5.18,"prevMonthClose":5.65,"prevQuarterClose":5.65,"fiveDayClose":5.25,"twentyDayClose":7.62,"sixtyDayClose":8.82,"dividendPayoutRate":0,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELV.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787875200000,"name":null,"time":"","dateTimestamp":1787839200000,"actualEps":null},{"date":"2026-07-28","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785196800000,"name":null,"time":"","dateTimestamp":1785160800000,"actualEps":null},{"date":"2026-04-23","symbol":"ELV.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776902400000,"name":null,"time":"Pre-MKt","dateTimestamp":1776866400000,"actualEps":null},{"date":"2026-02-24","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2026-01-28","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769554800000,"name":null,"time":"","dateTimestamp":1769518800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELV.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELV.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654021421","title":"Elevra Lithium Posts Lower Fiscal Q4 Spodumene Concentrate Production From Canada Operations; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654021421","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654021421?lang=en_us&edition=fundamental","pubTime":"2026-07-28 08:45","pubTimestamp":1785199501,"startTime":"0","endTime":"0","summary":"Elevra Lithium's  North American Lithium  operations in Canada produced 54,479 dry metric tonnes  of spodumene concentrate at an average grade of 5% in the fiscal fourth quarter, down from last year's 58,533 dmt of spodumene concentrate at an average grade of 5.2%, according to a Tuesday filing with the Australian bourse.The company reported NAL revenue of $31 million for the three months ended June, down on last quarter's $81 million, the filing said.The company recorded capital expenditure of $4 million during the quarter due to planned NAL sustaining capital projects and the NAL expansion scoping study.Shares fell nearly 3% in morning trade Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK7095","BK4585","SETM","LIT","ELV.AU","ELVR","BK4168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654402995","title":"Press Release: Elevra Lithium Quarterly Activities Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2654402995","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654402995?lang=en_us&edition=fundamental","pubTime":"2026-07-28 07:54","pubTimestamp":1785196440,"startTime":"0","endTime":"0","summary":"BRISBANE, Australia, July 28, 2026  -- Elevra Lithium Limited   delivered another strong operational performance, establishing monthly production records, and a Strategic Financing Package that enables near-term growth.North American Lithium-- Safety performance at North American Lithium  remained strong during. the June 2026 quarter, with no lost-time injuries recorded and continued. improvement in risk management and operational discipline across the. -- Ore mined remained stable quarter on quarter  with 372,938 wet. metric tonnes  mined in line with process plant requirements.-- Process plant utilisation remained high at 92% following a record March. shutdown. Strong crushing plant performance continued to support milling. grades resulted in lithium recoveries of 71% for the June 2026 quarter, a. metric tonnes  at an average grade of 5.0%. This was the second-best. produced in May 2026 when utilisation and recoveries peaked at 98% and. realised selling price  of US$921/dmt, resultin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIT","ELVR","BK4585","BK4588","ELV.AU","BK4168","BK7095","SETM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654067912","title":"Lynas Rare Earths Stock And 2 Australian Miners With Strong Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2654067912","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654067912?lang=en_us&edition=fundamental","pubTime":"2026-07-27 05:18","pubTimestamp":1785100697,"startTime":"0","endTime":"0","summary":"Markets are being pulled around by energy prices, geopolitical tension and shifting interest rate expectations, which makes it harder to spot companies with healthy foundations and clear earnings potential. The Healthy high growth potential screener filters for stocks where analysts see strong earnings growth over the next 3 years and balance sheets that meet reasonable financial quality checks. That combination can help you focus on businesses that are built to handle different macro...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/lynas-rare-earths-stock-and-2-australian-miners-with-strong-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/lynas-rare-earths-stock-and-2-australian-miners-with-strong-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SLF.AU","LYC.AU","DACE.AU","WGX.AU","ELV.AU","SETM","IOZ.AU","IMLC.AU","XJO.AU","EIGA.AU","ZYAU.AU","BEAR.AU","LIT","STW.AU","XAO.AU","VOTE","BK7506","BK7507","QRE.AU","E200.AU","IIGF.AU","IISV.AU","GEAR.AU","BK7095","QFN.AU","DECU","BBOZ.AU","XKO.AU","VAP.AU","BK7104","OZR.AU","JOYT","VAS.AU","FEBU","OZF.AU","GIVE.AU","VGFPF","PMDE","RGLO","BK4588","BK4585","GXDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654057508","title":"3 Australian Mining Stocks With Strong Balance Sheets And High Growth Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2654057508","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654057508?lang=en_us&edition=fundamental","pubTime":"2026-07-25 22:19","pubTimestamp":1784989172,"startTime":"0","endTime":"0","summary":"With investors watching everything from energy shocks to central bank decisions and uneven inflation, it is no surprise that strong earnings profiles and solid balance sheets are attracting attention. The Healthy high growth potential screener focuses on companies where analysts expect robust earnings expansion over the next 3 years, while still meeting basic financial health checks. That mix can appeal if you want exposure to growth without ignoring risk. In this article, the spotlight will...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/3-australian-mining-stocks-with-strong-balance-sheets-and-hi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/3-australian-mining-stocks-with-strong-balance-sheets-and-hi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BBOZ.AU","OZR.AU","JOYT","BK4585","BK7095","WGX.AU","RGLO","IISV.AU","ELV.AU","STW.AU","QRE.AU","E200.AU","LYC.AU","BK7104","IIGF.AU","DACE.AU","BK7506","OZF.AU","FEBU","GIVE.AU","QFN.AU","VAP.AU","DECU","IOZ.AU","IMLC.AU","VOTE","XJO.AU","BEAR.AU","VGFPF","GEAR.AU","XAO.AU","BK7507","EIGA.AU","GXDW","PMDE","SETM","BK4588","SLF.AU","LIT","XKO.AU","VAS.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653776648","title":"Elevance Health (ELV) Lifted Full Year Guidance, Is The 11% Undervaluation Still There?","url":"https://stock-news.laohu8.com/highlight/detail?id=2653776648","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653776648?lang=en_us&edition=fundamental","pubTime":"2026-07-24 03:29","pubTimestamp":1784834959,"startTime":"0","endTime":"0","summary":"Elevance Health (ELV) shares are in focus after the company paired its second quarter earnings release with higher full year 2026 diluted EPS guidance of at least $20.10, despite lower quarterly net income.\nSee our latest analysis for Elevance Health.\nThe share price reaction to Elevance Health's updated guidance has come after a stronger run earlier in the year, with the 90 day share price return up 12.36% and the 1 year total shareholder return at 33.94%. The 3 year total shareholder return...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-lifted-full-year-guidance-is-the-11-unde","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-lifted-full-year-guidance-is-the-11-unde","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1720051108.HKD","GXDW","LU2505996681.GBP","LU0061474960.USD","LU0314104364.USD","LU2430703178.SGD","LU0211331839.USD","FEBU","SG9999004303.SGD","BK4588","LU2357305700.SGD","LU0345770993.USD","LU1815333072.USD","ELV.AU","LU0433182093.SGD","LU2592432038.USD","JOYT","SG9999011175.SGD","LU2108987350.USD","LU1280957306.USD","LU0557290698.USD","PMDE","LU2237957902.USD","LU0742534661.SGD","LU0314106906.USD","LU2430703251.USD","LU0477156953.USD","BK4154","VGFPF","LU0106261372.USD","SGXZ23171101.USD","LU1057294990.SGD","LU0640476718.USD","LU1670627923.USD","RGLO","VOTE","LU0225283273.USD","LU0006306889.USD","LU0882574055.USD","LU0985489474.SGD","DECU","LU0058720904.USD","IHF","LU0068578508.USD","LU0114720955.EUR","LU0878866978.SGD","LU2244417387.USD","LU0957791311.USD","ELV","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653793917","title":"Elevra Lithium Schedules June Quarterly Results Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2653793917","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653793917?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:19","pubTimestamp":1784751548,"startTime":"0","endTime":"0","summary":"Elevra Lithium schedules June quarterly results webcastElevra Lithium scheduled its June 2026 quarterly activities report for release on July 28, 2026.Investor webcast on the quarterly results set for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDLbslHdL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652629307","title":"Elevance Health (ELV) Stock Still Looks Discounted Despite A 38% Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2652629307","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652629307?lang=en_us&edition=fundamental","pubTime":"2026-07-20 14:21","pubTimestamp":1784528490,"startTime":"0","endTime":"0","summary":"Elevance Health stock has delivered a strong 37.8% return over the past year, yet its valuation checks still point to shares looking inexpensive on several fronts. This raises the question of whether the recent pullback has left the stock trading below what its fundamentals may support.\n\nThe 37.8% gain over the last 12 months signals that Elevance Health has already rewarded shareholders. Any further upside case now rests more on valuation support than on a rerating from depressed...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-stock-still-looks-discounted-despite-a-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-stock-still-looks-discounted-despite-a-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0130517989.USD","LU0345770993.USD","LU0640476718.USD","LU2430703178.SGD","LU0557290698.USD","TSPA","LU2430703251.USD","BK7095","LU0345770308.USD","LU0477156953.USD","ELV","LU0234570918.USD","LU0058720904.USD","LU0985489474.SGD","SG9999004303.SGD","SGXZ23171101.USD","BK4585","LU1280957306.USD","LU2430703095.HKD","LU0006306889.USD","LU0061474960.USD","LU1720051017.SGD","LU0106261372.USD","LU0211331839.USD","LU2237957902.USD","SG9999001077.SGD","SG9999003800.SGD","LU1489326972.SGD","LU2362541273.HKD","LU0225283273.USD","LU2108987350.USD","LU0070302665.USD","LU1023059063.AUD","IHF","LU0251131958.USD","LU1670627923.USD","LU1815333072.USD","ELV.AU","LU2237957811.SGD","LU0878866978.SGD","LU1983299246.USD","LU0170899867.USD","LU0266013472.USD","LU0320765489.SGD","LU1057294990.SGD","LU2592432038.USD","LU0314106906.USD","LU0208291251.USD","LU1548497426.USD","LU2244417387.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652258542","title":"Elevance Health (ELV) Raises 2026 Targets And Exits Weak Medicaid Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2652258542","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652258542?lang=en_us&edition=fundamental","pubTime":"2026-07-19 02:21","pubTimestamp":1784398891,"startTime":"0","endTime":"0","summary":"Elevance Health (NYSE:ELV) raised its 2026 EPS guidance and operating cash flow targets following its Q2 results.\nThe company plans to exit underperforming Medicaid markets while continuing to invest in medical cost management and AI-enabled capabilities.\nManagement highlighted that these moves are intended to address membership declines, margin pressures, and a large accrual tied to Medicare risk adjustments.\n\nElevance Health is a major US managed care and health benefits company, with a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-raises-2026-targets-and-exits-weak-medic","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-raises-2026-targets-and-exits-weak-medic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RSPH","LU0225283273.USD","LU0130517989.USD","LU0314106906.USD","LU0251131958.USD","LU0211331839.USD","LU2430703178.SGD","LU2430703251.USD","SG9999004303.SGD","LU2505996681.GBP","LU0208291251.USD","LU2244417387.USD","LU1670627923.USD","LU0742534661.SGD","SG9999011175.SGD","LU1548497426.USD","BK7095","LU0878866978.SGD","BK4588","IHF","LU1506573853.SGD","LU2108987350.USD","LU1815333072.USD","LU1023059063.AUD","LU2362541273.HKD","LU1280957306.USD","LU1057294990.SGD","LU0289739699.SGD","LU0130102774.USD","LU0070302665.USD","LU0882574055.USD","LU0477156953.USD","LU0251142724.SGD","BK4154","LU2592432038.USD","ELV.AU","LU2237957902.USD","LU0187121727.USD","LU0058720904.USD","LU0980610538.SGD","LU0122379950.USD","LU0345770993.USD","LU1983299246.USD","LU0114720955.EUR","LU2362540622.SGD","ELV","LU1670628061.USD","LU1201861249.SGD","LU0345770308.USD","LU0557290698.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652282260","title":"Lynas Rare Earths Stock And 2 ASX Miners With Big Growth Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2652282260","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652282260?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:23","pubTimestamp":1784305380,"startTime":"0","endTime":"0","summary":"Markets are being pulled in different directions by inflation debates, shifting rate expectations, energy price swings and uneven growth across regions. In this kind of cross‑current, many investors look toward companies where analysts expect solid earnings growth over the next 3 years and balance sheets that can handle bumps in the road. That is exactly what the Healthy high growth potential screener aims to highlight. It focuses on stocks that combine growth potential with what analysts...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/lynas-rare-earths-stock-and-2-asx-miners-with-big-growth-pla","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/lynas-rare-earths-stock-and-2-asx-miners-with-big-growth-pla","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7507","LYC.AU","SRUUF","LIT","BK4585","BK7083","SETM","ELV.AU","URA","MVPS","PDN.AU","BK7509","BK7095","BK4588","BK4606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652421008","title":"Elevance Health's Strong Q2 Prompts Higher 2026-27 Estimates, Truist Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2652421008","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652421008?lang=en_us&edition=fundamental","pubTime":"2026-07-17 03:30","pubTimestamp":1784230252,"startTime":"0","endTime":"0","summary":"Elevance Health  strong Q2 results and higher 2026 guidance set the stage for improved long-term expectations, Truist Securities said Thursday in a report.Truist increased its 2026 EPS estimate to $27.12 from $26.84 and lifted its 2027 forecast to $29.14 from $29 after incorporating the Q2 beat and updated guidance.Q2 results topped expectations on revenue, medical loss ratio and adjusted EPS, helped by strong Medicare Advantage and Affordable Care Act performance, and Medicaid results were in line with management's expectations, the report said.Carelon, the health-services arm, continues to generate steady growth and cross-selling opportunities, with ongoing investments expected to improve operations across several areas, Truist said.Elevance raised its full-year cash-flow-from-operations guidance to at least $6 billion from $5.5 billion.Truist reiterated its buy rating on Elevance stock and maintained its $475 price target.Price: 373.43, Change: -16.90, Percent Change: -4.33","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0477156953.USD","SG9999001077.SGD","LU0114720955.EUR","LU0225283273.USD","LU0068578508.USD","LU0122379950.USD","LU0882574055.USD","SG9999011175.SGD","LU0985489474.SGD","LU1489326972.SGD","LU2430703251.USD","LU0208291251.USD","LU2237957811.SGD","LU1670628061.USD","BK4588","LU0048573561.USD","LU0058720904.USD","LU2108987350.USD","LU0289739699.SGD","LU1815333072.USD","SG9999004303.SGD","LU2362540622.SGD","LU0433182093.SGD","LU0061474960.USD","LU0320765489.SGD","LU0980610538.SGD","LU0106261372.USD","LU1670627923.USD","LU2430703178.SGD","ELV.AU","LU1506573853.SGD","BK4585","LU0130102774.USD","LU0640476718.USD","LU2362541273.HKD","LU2362541513.USD","LU0006306889.USD","LU0266013472.USD","LU2237957902.USD","LU0130517989.USD","LU0211331839.USD","LU2244417387.USD","LU0345770308.USD","LU1280957306.USD","SG9999003800.SGD","LU0187121727.USD","LU0234570918.USD","LU0251131958.USD","LU0070302665.USD","ELV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651442331","title":"Elevance Health Stock Weakness Despite Q2 Beat Reflects Medicaid Utilization Pressure, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2651442331","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651442331?lang=en_us&edition=fundamental","pubTime":"2026-07-16 23:03","pubTimestamp":1784214239,"startTime":"0","endTime":"0","summary":"Elevance Health  stock price decline despite a Q2 beat and upwardly revised full-year adjusted EPS guidance is primarily due to Medicaid utilization pressure among the continuing member base, RBC Capital Markets said in a research report emailed Thursday.Planned market exits over the next 18 months could also be cooling expectations around Medicaid recovery momentum, according to the note.The company's Q2 outperformance was partly driven by Medicare Advantage, alongside an $0.80 per share net benefit related to investment portfolio valuation adjustments, which it will redeploy into accelerated investments in H2, analysts wrote.The brokerage said it reiterated its sector perform rating on the stock and cut its price target to $424 per share from $439.Price: 376.68, Change: -13.66, Percent Change: -3.50","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128525929.USD","LU0234570918.USD","LU0878866978.SGD","LU2430703178.SGD","LU0708994859.HKD","SG9999003800.SGD","LU0314104364.USD","LU1023059063.AUD","LU2237957902.USD","LU1670627923.USD","LU1548497426.USD","BK4585","LU1983299246.USD","LU1489326972.SGD","IHF","LU2237957811.SGD","LU0289739699.SGD","BK4154","LU0314106906.USD","RSPH","LU0640476718.USD","LU0006306889.USD","BK4207","LU0320765489.SGD","LU2362540622.SGD","LU2430703095.HKD","ELV.AU","LU2244417387.USD","LU0029864427.USD","LU0345770308.USD","LU0058720904.USD","LU1720051108.HKD","GSIB","LU0477156953.USD","LU0048573561.USD","LU1720051017.SGD","LU0070302665.USD","LU2592432038.USD","LU0266013472.USD","LU0980610538.SGD","BK4588","LU2505996509.AUD","LU2505996681.GBP","LU0106261372.USD","SG9999011175.SGD","LU0187121727.USD","ELV","LU0882574055.USD","LU2430703251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651447506","title":"Is Elevra Lithium (ASX:ELV) Undervalued Following Its Fully Funded North American Lithium Expansion?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651447506","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651447506?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:33","pubTimestamp":1784205191,"startTime":"0","endTime":"0","summary":"Elevra Lithium (ASX:ELV) has set out a fully funded plan to expand production at its North American Lithium operation, supported by an institutional placement, a Canada Growth Fund convertible note, and Ewoyaa stake sale proceeds.\nSee our latest analysis for Elevra Lithium.\nElevra Lithium’s latest expansion plan lands after a sharp 32.67% decline in the 30 day share price return and a 15.03% fall over 90 days, yet the year to date share price return of 11.36% and a very large 1 year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/is-elevra-lithium-asxelv-undervalued-following-its-fully-fun","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/is-elevra-lithium-asxelv-undervalued-following-its-fully-fun","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999003800.SGD","IHF","BK4585","LU0122379950.USD","LU0251131958.USD","BK7095","BK4588","LU1280957306.USD","LU2362540622.SGD","LU0006306889.USD","LU0130102774.USD","LIT","LU2108987350.USD","AFG","LU0320765489.SGD","ELV.AU","LU1506573853.SGD","LU0314106906.USD","LU0314104364.USD","ELV","LU2237957811.SGD","LU0058720904.USD","LU1023059063.AUD","LU0211331839.USD","LU0070302665.USD","LU2505996509.AUD","LU0882574055.USD","LU2430703178.SGD","SG9999004303.SGD","SGXZ23171101.USD","LU2244417387.USD","SG9999001077.SGD","LU0187121727.USD","SETM","LU0980610538.SGD","LU0433182093.SGD","LU0289739699.SGD","LU0345770993.USD","LU1815333072.USD","LU1983299246.USD","LU0208291251.USD","LU2505996681.GBP","LU0640476718.USD","LU2592432038.USD","LU0345770308.USD","LU0266013472.USD","LU2430703095.HKD","LU0130517989.USD","LU0477156953.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651349486","title":"Elevra Lithium Ltd-elv Egm - Chair Address and Egm Slides","url":"https://stock-news.laohu8.com/highlight/detail?id=2651349486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651349486?lang=en_us&edition=fundamental","pubTime":"2026-07-16 07:37","pubTimestamp":1784158652,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUE5ZSBJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651491498","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2651491498","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651491498?lang=en_us&edition=fundamental","pubTime":"2026-07-16 02:39","pubTimestamp":1784140793,"startTime":"0","endTime":"0","summary":"Pentair  reported preliminary Q2 results below market estimates and lowered its full-year outlook amid headwinds related to its pool segment.Pentair CFO Nick Brazis' unexpected departure, just four months after his appointment, adds near-term skepticism on the stock, RBC said in a note. RBC downgraded the stock to sector perform from outperform.Shares slumped 14%, with intraday trading volume rising to more than 8.5 million from a daily average of about 2.3 million.Elevance Health  reported sequential and annual declines in membership for Q2, although the health insurer lifted its full-year earnings outlook and recorded an unexpected year-over-year revenue increase.Shares declined 8.7% as intraday trading volume jumped to over 2.4 million from a daily average of about 1.7 million.Evercore ISI cut its Progressive's  price target to $230 from $240 following the release of the company's Q2 results.Shares declined 9%, with intraday trading volume of over 3.8 million against a daily average","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELV","LU0070302665.USD","LU1481011911.USD","LU1201861249.SGD","LU0061474960.USD","AQWA","LU0314104364.USD","LU1481011671.HKD","LU0640476718.USD","LU0353189680.USD","PGR","PNR.AU","LU0187121727.USD","LU2430703251.USD","LU0225283273.USD","LU2244417387.USD","KBWP","LU1989763690.USD","IAK","LU1989763427.SGD","LU0742537680.HKD","SG9999004303.SGD","LU2413665964.HKD","LU1815333072.USD","LU1585245621.USD","LU1892829315.USD","LU0175139822.USD","LU2087625088.SGD","LU1721428933.USD","LU1974910355.USD","LU2229751404.USD","LU0048573561.USD","LU1543694498.USD","PNR","LU0211331839.USD","IE00BJJMRX11.SGD","ELV.AU","LU0320765489.SGD","IE00BZ1G4Q59.USD","LU1917777945.USD","LU2430703095.HKD","LU2237957811.SGD","LU0122379950.USD","LU0208291251.USD","BK4154","IHF","IE00BFSS8Q28.SGD","LU0354030438.USD","BK4161","LU0477156953.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651850454","title":"GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS of At Least $27, vs. FactSet Est of $26.87","url":"https://stock-news.laohu8.com/highlight/detail?id=2651850454","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651850454?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:13","pubTimestamp":1784110390,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS of At Least $27, vs. FactSet Est of $26.87","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELV.AU","ELV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651168361","title":"US Stock Market Today: S&P 500 Futures Climb On Cooler Global Inflation And Yields","url":"https://stock-news.laohu8.com/highlight/detail?id=2651168361","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651168361?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:30","pubTimestamp":1783931431,"startTime":"0","endTime":"0","summary":"The Morning Bull - US Market Morning Update Monday, Jul, 13 2026\nUS stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 0.4%, and investors are weighing two big forces. First, global inflation signals are mixed but generally calmer, with June readings in France at 1.8% and the Czech Republic at 1.5%, which in plain terms means price pressures in several key economies are closer to central bank comfort zones. Second, government bond yields in the US, Japan,...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/128680956-main-header/1756229826628","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/128680956-main-header/1756229826628"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/us-stock-market-today-sp-500-futures-climb-on-cooler-global","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/us-stock-market-today-sp-500-futures-climb-on-cooler-global","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LGH",".SPX","ELV","SBAC","FDFF","JNJ","SPYM","FEBT","VOOG","XPAY","CPST","ELV.AU","XUSP","CFO","SCHG","FLAO","PTL","BKLC","VOO","SPY","CBRS","ISSXF","FELC","MDB","UOCT","PTLC","BAC","FLCC","META","OKTA","TSPA","BLK.AU","GSUS","MRCP","GBXB","VOTE","PBJL","CGUS","ACLC","MRNA","OALC","CUL3","BLK","UAL","UXJA","VUG","GPIX","HELO","DECU","VYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651169790","title":"Elevance Health (ELV) Stock Looks Reasonable On Earnings But Stretched After 25% Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2651169790","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651169790?lang=en_us&edition=fundamental","pubTime":"2026-07-13 06:23","pubTimestamp":1783895038,"startTime":"0","endTime":"0","summary":"Elevance Health stock has gained 24.7% over the past year, and the latest valuation checks still lean toward the shares looking inexpensive rather than stretched at recent levels.\n\nThe 24.7% one year return suggests investors have already been willing to pay more for Elevance Health, yet the current pricing still leaves room for the question of whether the stock fully reflects its fundamentals.\nConfidence around Elevance Health's margin outlook and efficiency efforts, alongside ongoing legal...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-stock-looks-reasonable-on-earnings-but-s","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-stock-looks-reasonable-on-earnings-but-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELV.AU","ELV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650358906","title":"Australia's Elevra Lithium Falls to Near Three-month Low on Lower Production, Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2650358906","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650358906?lang=en_us&edition=fundamental","pubTime":"2026-07-10 10:38","pubTimestamp":1783651088,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Elevra Lithium falls to near three-month low on lower production, sales** Shares of Elevra LithiumELV.AXfall nearly 3% to A$8.775, their lowest level since April 15** Cosaysits North American lithium operation in Canada produced 54,479 dry metric tons  of spodumene concentrate and recorded sales of 33,977dmt in qtr** Sayona Mining, which merged with Piedmont Lithium to create ELV, delivered quarterly production of 58,533 dmt. and spodumene sales of 66,980 dmt from the same project** Stock up about 9% YTD, including moves in current session","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nL4N43C05K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELV.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650253905","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2650253905","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650253905?lang=en_us&edition=fundamental","pubTime":"2026-07-10 10:14","pubTimestamp":1783649689,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest losses on Friday.Electro Optic Systems Holdings : -6%, AU$8.38Pro Medicus : -5%, AU$199.56Tamboran Resources : -4%, AU$0.23Elevra Lithium : -4%, AU$8.67Austal : -4%, AU$3.77EVT : -3%, AU$12.33Telix Pharmaceuticals : -3%, AU$16.36Marimaca Copper : -3%, AU$7.51SiteMinder : -3%, AU$3.79Codan : -3%, AU$43.25","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ASB.AU","EVT.AU","BK7067","BK7016","BK7142","SDR.AU","TLX.AU","BK7095","MC2.AU","BK7115","ELV.AU","TBN.AU","CDA.AU","BK7084","EOS.AU","BK7094","BK7035","PME.AU","BK7110"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2650903176","title":"Elevra Lithium Says North American Lithium Produces 54,479 Dmt Spodumene Concentrate in June Qtr","url":"https://stock-news.laohu8.com/highlight/detail?id=2650903176","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650903176?lang=en_us&edition=fundamental","pubTime":"2026-07-10 09:24","pubTimestamp":1783646657,"startTime":"0","endTime":"0","summary":"July 10 (Reuters) - Elevra Lithium Ltd::*NORTH AMERICAN LITHIUM PRODUCES 54,479 DMT SPODUMENE CONCENTRATE, SALES OF 33,977 DMT IN JUNE 2026 QUARTER*Further company coverage: ELV.AX* ((Reuters.Briefs@t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nRSD8DqpXw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELV.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":132,"code":"91000000","status":"200"}]}}